Fareston

Kyowa Kirin, Inc.🇺🇸 United States

FDA Page

Effective Date: Sep 15, 2023
Approval ID: 2cab8dd1-3a10-48e6-86ce-0e5275ed49e5
Products: 1 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use FARESTON® safely and effectively. See full prescribing information for FARESTON®. FARESTON® (toremifene citrate) 60 mg Tablets oral administration Initial U.S. Approval: 1997

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.